Welcome to our dedicated page for Neutra news (Ticker: NTRR), a resource for investors and traders seeking the latest updates and insights on Neutra stock.
Neutra Corp (NTRR) is a Texas-based innovator in hemp-derived wellness products, including CBD tinctures and clinical-grade topicals. This news hub provides investors and industry observers with essential updates on the company's strategic initiatives and market expansion.
Discover official announcements ranging from product innovations to financial developments, all supporting Neutra Corp's mission to lead in natural wellness solutions. The curated collection includes updates on manufacturing advancements, regulatory compliance progress, and partnership developments within the specialty healthcare sector.
Key focus areas mirror the company priorities outlined in its two-year management plan: direct-to-consumer platform growth, clinical research investments, and educational consulting services expansion. Users will find timely updates on operational milestones including production capacity increases and distribution network enhancements.
Bookmark this page for streamlined access to Neutra Corp's evolving position in the competitive wellness market. Verify time-sensitive details through official SEC filings and corporate communications linked where available.
Neutra Corp. (OTC PINK:NTRR) has acquired Deity Wellness, a brand specializing in hemp-based products, including Delta-8 gummies. This acquisition positions Neutra to enter the burgeoning Delta-8 THC market, especially after Texas's decision not to ban the substance. The move allows Neutra to quickly introduce a market-ready product, enhancing its competitive edge. Neutra will maintain both the Deity Wellness and VIVIS brands, targeting both recreational and medicinal consumers. Analysts project significant growth in the CBD market, anticipating it will reach over $25 billion by 2025.
Neutra Corp. (OTC PINK:NTRR) is set to launch a range of Delta-8 THC products following the failure of a proposed ban in the Texas Legislature. The company's CEO, Sydney Jim, noted strong market demand and readiness to begin production. While Delta-8 THC is less psychoactive compared to Delta-9, it can be legally manufactured from hemp in Texas. The potential market for Delta-8 is expected to expand as more states legalize its use, positioning Neutra to benefit significantly from this growing trend.
Neutra Corp. (OTC PINK:NTRR) is exploring opportunities in clinical research to innovate cannabis applications and enhance CBD products. Following successful sales of CBD lotions, topicals, and gummies, the company aims to integrate clinical research into its growth strategy, which CEO Sydney Jim believes will unlock new revenue streams and increase shareholder value. The cannabis market, which saw a remarkable 67% growth in 2020, is projected to expand by 21% annually, potentially reaching $73.6 billion by 2027.
Neutra Corp. (OTC PINK:NTRR) has secured a distribution agreement with a Mexican company, paving the way for its VIVIS CBD product line in Mexico. This strategic move could open international markets for the company. The Mexican hemp-based CBD market, valued at $9 to $47 million in 2019, is projected to grow to over $275 million by 2025. Neutra's sales reached a record high in March 2021, attributed to the efforts of a new national sales team and easing COVID-19 restrictions. The company aims to capitalize on the growing consumer demand for healthy living products.
Neutra Corp. (OTC PINK:NTRR) is exploring opportunities in the home health and hospice care sector, specifically targeting the Baby Boomer demographic. CEO Sydney Jim highlighted the potential for CBD products to provide relief for this aging population, who are increasingly dealing with bodily pains and mental anxiety. With about 71 million Baby Boomers in the U.S., there is a growing interest in CBD, with 8% currently using it. Neutra aims to tap into this market, offering high-quality CBD options to cater to their needs.
Neutra Corp. (OTC PINK:NTRR) is advancing its application to become a vendor at a major regional big box store chain. This move is aimed at expanding the reach of its subsidiary, VIVIS, which offers lab-tested CBD products. Following a successful launch at a local retail outlet, VIVIS has received positive feedback from customers. Neutra plans to explore additional business opportunities to enhance revenue and shareholder value. The company anticipates announcing new ventures soon to support further growth.
Neutra Corp. (OTC PINK:NTRR) has become a vendor for the Pasadena Medical Plaza Pharmacy, with VIVIS-branded CBD products expected to be available starting May 12, 2021. CEO Sydney Jim highlighted this as a strategic win, as the location is adjacent to the Pasadena Health Center, targeting customers suffering from chronic pain. Additionally, Neutra's recent efforts include a successful launch at Restore Hyper Wellness in Houston and potential vendor agreements with three regional box store chains. The company aims to tap into the growing hemp-based CBD market.
Neutra Corp. (OTC PINK:NTRR) announced a highly successful launch party on May 1 at Restore Hyper Wellness in Houston, where nearly all initial VIVIS product stock was sold. Customers showed strong interest, leading the retailer to prepare a follow-up order. CEO Sydney Jim praised the event, highlighting customer enthusiasm for VIVIS's quality and rigorous lab testing. This launch follows Neutra's recent listing on Zoovu and its anticipation of becoming a vendor for several regional box store chains, signaling significant momentum in the hemp-based CBD market.
Neutra Corp. (OTC PINK:NTRR) has joined the Zoovu platform, enhancing its subsidiary VIVIS's visibility in the CBD market. This partnership allows customers to easily find lab-tested CBD products through AI-driven searches. Neutra's CEO, Sydney Jim, noted this move enables better customer engagement and growth. VIVIS will be among the first CBD brands on Zoovu, which also serves clients like Microsoft and Amazon. Additionally, Neutra is negotiating with major retailers and exploring opportunities in the Mexican market, having set a new sales record in March.
Neutra Corp. (OTC PINK:NTRR) is negotiating with a Mexican company to distribute VIVIS-manufactured CBD products in Mexico. This agreement aims to bolster their international presence, following Neutra's record sales in March 2021. The Mexican CBD market is projected to grow significantly, reaching over $275 million by 2025. Neutra's CEO, Sydney Jim, highlighted the opportunity for growth and the potential of their lab-tested CBD products. The company’s strong sales performance is attributed to the reopening of retail spaces post-COVID-19 pandemic.
